Clean Science & Technology Ltd
Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]
- Market Cap ₹ 13,950 Cr.
- Current Price ₹ 1,313
- High / Low ₹ 1,622 / 1,277
- Stock P/E 54.9
- Book Value ₹ 103
- Dividend Yield 0.38 %
- ROCE 44.5 %
- ROE 33.2 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 43.3% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.4%
- Company has been maintaining a healthy dividend payout of 55.6%
Cons
- Stock is trading at 12.8 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|
241 | 393 | 419 | 512 | 685 | 936 | 781 | |
167 | 257 | 234 | 253 | 385 | 533 | 438 | |
Operating Profit | 74 | 137 | 186 | 260 | 300 | 403 | 343 |
OPM % | 31% | 35% | 44% | 51% | 44% | 43% | 44% |
5 | 11 | 11 | 25 | 30 | 30 | 40 | |
Interest | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
Depreciation | 8 | 11 | 14 | 17 | 25 | 36 | 43 |
Profit before tax | 70 | 137 | 182 | 267 | 305 | 396 | 339 |
Tax % | 30% | 28% | 23% | 26% | 25% | 25% | |
49 | 98 | 140 | 198 | 228 | 295 | 254 | |
EPS in Rs | 345.41 | 689.84 | 1,051.67 | 18.68 | 21.51 | 27.78 | 23.93 |
Dividend Payout % | 12% | 15% | 2% | 134% | 15% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 31% |
3 Years: | 31% |
TTM: | -15% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 43% |
3 Years: | 28% |
TTM: | -8% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -9% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 38% |
3 Years: | 36% |
Last Year: | 33% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|
Equity Capital | 1 | 1 | 1 | 11 | 11 | 11 | 11 |
Reserves | 186 | 271 | 341 | 529 | 758 | 999 | 1,080 |
1 | 3 | 3 | 0 | 0 | 2 | 3 | |
48 | 53 | 85 | 120 | 156 | 140 | 137 | |
Total Liabilities | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,231 |
102 | 127 | 166 | 186 | 296 | 460 | 452 | |
CWIP | 2 | 4 | 3 | 55 | 44 | 20 | 139 |
Investments | 18 | 75 | 133 | 232 | 191 | 353 | 343 |
114 | 121 | 128 | 187 | 394 | 318 | 297 | |
Total Assets | 236 | 327 | 430 | 660 | 925 | 1,152 | 1,231 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
45 | 85 | 160 | 193 | 127 | 279 | |
-17 | -94 | -105 | -187 | -79 | -270 | |
-5 | -11 | -55 | -6 | -0 | -55 | |
Net Cash Flow | 23 | -20 | -0 | 0 | 49 | -45 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
Debtor Days | 60 | 55 | 61 | 53 | 82 | 57 |
Inventory Days | 93 | 79 | 98 | 156 | 143 | 122 |
Days Payable | 85 | 48 | 101 | 180 | 166 | 90 |
Cash Conversion Cycle | 69 | 87 | 58 | 29 | 59 | 89 |
Working Capital Days | 60 | 64 | 35 | 32 | 90 | 68 |
ROCE % | 59% | 59% | 61% | 47% | 44% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - A conference call for analysts and investors has been scheduled on Wednesday, 15th May, 2024 at 4:00 pm (IST) to discuss the audited financial results …
- Board Meeting Intimation for Consideration Of Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2024 And Recommendation Of Final Dividend For The Financial Year Ended 31St March, 2024 20 Apr
-
Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015.
16 Apr - Listing Regulations, 2015 please find enclosed certificate dated 15th April, 2024 received from J B Bhave & Co., Practicing Company Secretaries for the financial year …
- Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (LODR) Regulations, 2015. 15 Apr
-
Announcement under Regulation 30 (LODR)-Acquisition
5 Apr - Investment in Clean Fino-Chem Limited -wholly owned subsidiary.
Concalls
-
Feb 2024Transcript PPT REC
-
Jan 2024TranscriptNotesPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT REC
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
Product Segments & Revenue split FY22
Performance chemicals (70%): 4 key products are MEHQ, BHA, AP and TBHQ. [1]